S100A3

S100A3 is a cysteine-rich EF-hand protein of the S100 family encoded in the chromosome 1q21 S100 cluster, distinguished from its relatives by an unusually high cysteine content (PMID:8341667). It is a non-covalent dimer that binds Ca2+ with low affinity (Kd ~4 mM) and Zn2+ with high affinity through thiolate-bridged metal clusters, including a (Cys)3His coordination site (PMID:9920417, PMID:21377473). High-resolution crystal structures show that the C-terminal canonical EF-hand is distorted in the apo state and that Zn2+ binding drives large conformational changes at the hydrophobic dimer interface; two intramolecular disulfide bridges, Cys30–Cys68 (SS1) and Cys81–Cys99 (SS2), gate both Ca2+ binding and citrullination, with SS1 disruption abolishing Ca2+ binding and SS2 disruption increasing Ca2+ affinity (PMID:12045193, PMID:21377473). The protein is the predominant ~7 kDa component of human hair cuticle, localizing to the endocuticle and intermacrofibrillar matrix (PMID:8672544, PMID:10082754), where PAD3 specifically citrullinates Arg-51; this single modification is essential for assembling a stable Ca2+/Zn2+-bound globular homotetramer that expands upon metal binding rather than aggregating, supporting hair cuticle and follicle maturation (PMID:18083705, PMID:32149230, PMID:26535667). Beyond hair, S100A3 directly binds the ligand-binding domain of RARα (via residue I396) to stabilize RARα protein and modulate ATRA signaling in cancer cells, and its loss reduces viability and invasion in prostate cancer through downregulation of MMP-2/MMP-9 (PMID:30532072, PMID:25440760). Digenic co-inheritance of a hypomorphic S100A3 variant with a truncating S100A13 mutation causes familial pulmonary fibrosis, in which reduced S100A3 disrupts intracellular Ca2+ homeostasis and mitochondrial function—defects reversed by restoring wild-type protein (PMID:31073086, PMID:38099297).

1. 1993 Medium

   Established S100A3 as a distinct S100 family member, defining its genomic context and its hallmark high cysteine content that would later prove central to its metal chemistry.

   Evidence Pulsed-field gel electrophoresis and genomic sequencing mapping the 1q21 S100 cluster

   PMID:8341667

   Open questions at the time

   • No functional or biochemical activity assigned
   • Tissue distribution and physiological role unknown at this stage
2. 1996 Medium

   Identified the native physiological context of S100A3 by showing it is the dominant protein of the hair cuticle, anchoring later structural and PTM work to a specific tissue.

   Evidence Peptide sequencing, immunoblotting and immunofluorescence on human hair fibers

   PMID:8672544

   Open questions at the time

   • Molecular function within the cuticle not defined
   • Did not address metal binding or oligomeric state
3. 1999 Medium

   Refined the localization to the endocuticle and intermacrofibrillar matrix, placing S100A3 spatially distinct from keratins and implying a non-structural-fiber role.

   Evidence Rapid-freezing immunoelectron microscopy with double immunolabeling

   PMID:10082754

   Open questions at the time

   • Functional consequence of this localization unresolved
   • No interacting partners identified
4. 1998 Medium

   Defined S100A3's unusual metal-binding behavior—weak Ca2+ but high-affinity Zn2+ via cysteine thiolate clusters—reframing it as a Zn2+-centered rather than canonical Ca2+ sensor.

   Evidence Anaerobic recombinant purification with spectrophotometric metal titration, SEC and CD

   PMID:9920417

   Open questions at the time

   • Atomic coordination geometry not yet resolved
   • Physiological metal occupancy in vivo unknown
5. 2002 High

   Provided the first atomic structures, explaining weak Ca2+ binding through a distorted C-terminal EF-hand and revealing a C-terminal Zn2+ site and Zn2+-induced interface rearrangement.

   Evidence X-ray crystallography of apo-S100A3 (1.7 Å and MIRAS-phased structures) with SEC/CD

   PMID:12045193 PMID:12136135

   Open questions at the time

   • Metal-bound structure not captured
   • Functional oligomeric assembly not yet linked to structure
6. 2002 Medium

   Characterized a native N-terminal acetylation PTM, distinguishing tissue-derived S100A3 from recombinant protein and flagging post-translational regulation.

   Evidence 2D gel electrophoresis and LC-MS/MS on cuticle-purified protein

   PMID:12470658

   Open questions at the time

   • Functional impact of N-acetylation untested
   • Did not address citrullination
7. 2007 High

   Identified PAD3-specific citrullination of Arg-51 as the key activating modification that converts S100A3 into a stable tetramer with enhanced Ca2+ binding, linking an enzyme to functional assembly in hair.

   Evidence PAD enzymatic assays, citrulline-antibody Western blot, R51A mutagenesis, gel filtration and Ca2+ fluorimetry with PAD3 co-localization in tissue

   PMID:18083705

   Open questions at the time

   • Structural basis of tetramerization not resolved here
   • Downstream cuticle assembly partners unknown
8. 2011 High

   Mapped two intramolecular disulfide bridges and showed they oppositely gate Ca2+ binding and PAD3 reactivity, mechanistically coupling redox state to metal binding and citrullination.

   Evidence High-resolution crystallography (1.40–2.15 Å) with site-directed mutagenesis, PAD3 and Ca2+ binding assays

   PMID:21377473

   Open questions at the time

   • In vivo redox regulation of the bridges untested
   • Citrullinated-state structure not obtained
9. 2020 High

   Used the R51Q citrullination mimic to demonstrate directly that Arg-51 modification is required for an ordered Ca2+/Zn2+-bound tetramer that expands rather than aggregates, resolving the assembly mechanism.

   Evidence SEC-SAXS, DLS, Trp-fluorescence Ca2+ titration on R51Q versus WT

   PMID:32149230

   Open questions at the time

   • High-resolution tetramer structure still lacking
   • Functional output of the tetramer in the cuticle not directly tested
10. 2015 Medium

    Demonstrated a physiological requirement for S100A3 in hair growth, with antibody blockade delaying anagen entry and reducing follicle number, connecting the cuticle protein to follicle cycling.

    Evidence Subcutaneous antibody blockade in a depilation-induced mouse hair model with IHC and expression microarray

    PMID:26535667

    Open questions at the time

    • Mechanism downstream of blockade unclear
    • Antibody specificity/off-target effects not fully excluded
11. 2018 Medium

    Revealed an unexpected cancer-related function by showing S100A3 binds the RARα ligand-binding domain to stabilize the receptor and tune ATRA responses, extending its role beyond hair.

    Evidence Co-IP interactome, I396 mutagenesis, siRNA knockdown and protein stability/differentiation assays in cancer cell lines

    PMID:30532072

    Open questions at the time

    • Whether metal binding/citrullination modulates RARα interaction unknown
    • Single-lab finding without reciprocal in vivo validation
12. 2014 Medium

    Linked S100A3 to tumor cell survival and invasion through MMP regulation, identifying a pro-tumorigenic loss-of-function phenotype in prostate cancer.

    Evidence shRNA knockdown with viability, apoptosis, invasion, zymography and xenograft assays

    PMID:25440760

    Open questions at the time

    • Direct molecular link between S100A3 and MMP transcription not established
    • Relationship to RARα pathway not explored
13. 2019 Medium

    Connected S100A3 to human disease, showing digenic co-inheritance with S100A13 causes familial pulmonary fibrosis with Ca2+ and mitochondrial defects in patient fibroblasts.

    Evidence Molecular genetics with patient-derived fibroblast Ca2+, mitochondrial and expression assays

    PMID:31073086

    Open questions at the time

    • Mechanism coupling S100A3 loss to mitochondrial dysfunction undefined
    • Relative contribution of S100A3 versus S100A13 not separated
14. 2023 Medium

    Established causality for the fibrosis phenotype by showing wild-type S100A3 (intracellular or recombinant extracellular) rescues Ca2+ signaling, mitochondrial mass/potential and inflammatory output.

    Evidence WT/mutant transfection and recombinant protein rescue in patient-derived fibrosis cells

    PMID:38099297

    Open questions at the time

    • Molecular receptor/effector for extracellular S100A3 unknown
    • Link to citrullination/tetramerization chemistry untested
15. 2017 Low

    Placed S100A3 citrullination within an ALOX12–HBEGF–PADI regulatory axis, suggesting upstream pharmacological control of its activating modification.

    Evidence Pharmacological ALOX12 inhibition and correlative microarray in SW480 cells and human hair follicles with HBEGF treatment

    PMID:28381806

    Open questions at the time

    • Indirect, correlative pathway placement without direct enzymatic linkage
    • Effect on S100A3 function not measured
16. 2023 Low

    Implicated S100A3 as a host factor supporting HBV replication, broadening its potential disease relevance.

    Evidence siRNA knockdown and overexpression with HBV DNA/antigen quantification and an rAAV-HBV mouse model

    PMID:37207431

    Open questions at the time

    • No molecular mechanism for the HBV effect established
    • Single-lab, mechanism-free correlation

• How S100A3's metal-binding/citrullination-driven tetramerization chemistry mechanistically connects to its disparate roles in RARα stabilization, MMP-driven invasion, and mitochondrial/Ca2+ homeostasis remains unresolved.
• No unified mechanism linking the structural chemistry to cancer and fibrosis functions
• Extracellular receptor/effector for secreted S100A3 unidentified
• Whether citrullination occurs in non-hair contexts unknown